Phototherapy Device Market to Reach USD 860.30 Million by 2032 at 4.1% CAGR

Key Highlights

• The Phototherapy Device Market was valued at USD 649.37 million in 2025 and is expected to reach USD 860.30 million by 2032 at a 4.1% CAGR, keeping the category in a steady equipment replacement and adoption cycle.
• North America held 55% of the market in 2025, supported by high skin-disorder prevalence and neonatal jaundice treatment demand.
• Conventional phototherapy generated USD 184.00 million in 2025 and remains the dominant technology segment.
• LED-based phototherapy is projected to grow at a 6.0% CAGR, making it the fastest-growing technology segment disclosed by MMR.
• Hospitals and specialty clinics were valued at USD 378.0 million in 2025, confirming institutional care as the leading treatment channel.

Why This Matters Now

The Phototherapy Device Market is being pulled in two directions: hospitals need dependable treatment capacity for neonatal jaundice and chronic skin disease, while patients increasingly want convenient care outside hospital settings. Device companies therefore compete on clinical utility, light-source efficiency, portability and ease of treatment.

MMR reports that acne affects 50 million people in the United States every year, while 31.6 million Americans suffer from skin and acne disorders. The scale of recurring dermatology demand creates a continuing treatment opportunity rather than a one-time equipment cycle.

Market Overview

Phototherapy exposes patients to controlled fluorescent, LED, halogen or other light sources to manage specific medical conditions. The Phototherapy Device Market serves dermatology and neonatal care, with applications including psoriasis, vitiligo, eczema and neonatal jaundice.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/121745/

MMR values the Phototherapy Device Market at USD 649.37 million in 2025 and forecasts USD 860.30 million by 2032, representing a 4.1% CAGR. That measured expansion gives manufacturers room to improve treatment economics and broaden access across institutional and home settings.

Key Trends Driving Growth

Skin disease prevalence is the first structural growth engine. The Phototherapy Device Market benefits from demand for light-based treatment across psoriasis, eczema, vitiligo and other dermatological conditions, increasing equipment requirements within specialty care.

Neonatal treatment is the second driver. MMR cites rising preterm and low-birth-weight births and states that 100,000 people in the UK and Ireland experienced hyperbilirubinemia in 2025. Phototherapy's ability to reduce bilirubin creates continued demand for neonatal treatment equipment.

Technology is moving toward LED systems. The Phototherapy Device Market is benefiting from rising adoption of LED-based treatment, while D-Rev introduced an LED solution for neonatal jaundice. The transition gives manufacturers an opportunity to differentiate through treatment performance, device design and usability.

Home treatment creates another commercial opening. MMR says home phototherapy reduces the need for frequent hospital visits and can be an effective treatment option for patients with moderate to severe psoriasis. The report does not provide separate reimbursement, telehealth or digital-health statistics, so those areas should not be quantified.

Segment Insights

• Dominant Technology Segment  Conventional Phototherapy: Conventional phototherapy generated USD 184.00 million in 2025 and is identified as the dominant segment. It remains widely used to reduce hyperbilirubinemia in newborns and treat skin diseases.
• Fastest-Growing Technology Segment  LED-Based Phototherapy: LED-based phototherapy is the second-largest technology category and is projected to grow at a 6.0% CAGR. Its faster growth highlights the industry's shift toward newer light-source technologies.
• Fiber Optic Phototherapy: Fiber optic systems complete the technology segmentation. MMR lists the category but does not publish a separate share, revenue value or CAGR on the accessible report page.
• Skin Disease Treatment: The application includes psoriasis, vitiligo and eczema and is projected to grow at a 5.44% CAGR. Rising skin-disorder prevalence sustains demand for repeat phototherapy sessions.
• Neonatal Jaundice Management: Neonatal jaundice is expected to witness strong growth during the forecast period. The opportunity is linked to jaundice incidence among newborns and demand for bilirubin-reduction treatment.
• Dominant End User — Hospitals and Specialty Clinics: Hospitals and specialty clinics were assessed at USD 378.0 million in 2025 and are expected to hold the highest share. Patients continue to favour institutional treatment because of available facilities and newer techniques.
• Home User: Home users represent the other end-user category in the Phototherapy Device Market. Convenience and fewer hospital visits strengthen the case for home treatment, particularly where patients need repeated dermatology sessions.

Regional Growth Story

North America dominated the Phototherapy Device Market with a 55% share in 2025 and is expected to register a 4.63% CAGR. High prevalence of skin disorders and neonatal jaundice supports continued equipment demand, with the United States forming the region's main clinical market.

Europe held 35% of the market in 2025 and is expected to grow at a 4.23% CAGR. The UK and Ireland's reported hyperbilirubinemia burden strengthens neonatal demand. Germany and the UK are included in MMR's analysis, although standalone country values are not disclosed publicly.

China is projected to reach USD 216.4 million by 2030 and is associated with a 5.1% CAGR in the report. Higher healthcare expenditure in China and India is also cited as a growth factor. Japan, India and South Korea are covered regionally without separate public market values.

Competitive Landscape

Competition in the Phototherapy Device Market spans diversified healthcare companies and specialist phototherapy manufacturers. GE Healthcare, Atom Medical, Draeger, Herbert Waldmann, Natus Medical, Daavlin, Beurer, National Biological, Solarc Systems and UVBioTek are among the participants identified by MMR.

The competitive issue is broader than product availability. Hospitals prioritize clinical reliability and facilities, while home users value convenience. Companies able to address both settings gain wider access to patients and reduce dependence on a single treatment channel.

Lumie's Spark 100 and Glow 150 illustrate continued product development in controlled-light technologies. Although focused on sleep and wake cycles rather than neonatal or dermatology treatment, they demonstrate broader innovation around therapeutic light delivery.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/121745/

Recent Developments

• D-Rev, Design Revolution: Introduced an LED-based solution for neonatal jaundice treatment. The development supports greater use of LED systems in bilirubin management and highlights the opportunity for simpler neonatal-care technologies.
• Lumie: Launched Spark 100 and Glow 150 sleep/wakeup lights with adjustable light functions. The products indicate continued diversification of controlled-light technologies across healthcare and wellness applications.

Strategic Implications

For healthcare providers, purchasing decisions are moving beyond basic light delivery. The Phototherapy Device Market increasingly requires attention to treatment throughput, patient comfort, equipment installation, maintenance and suitability for repeated treatment.

For manufacturers in the Phototherapy Device Market, LED technology creates the clearest disclosed growth opportunity, but regulation remains a barrier. MMR identifies stringent FDA and government approval requirements, manufacturing costs and installation expenses as factors that can restrict expansion.

Awareness remains another constraint. MMR cites limited understanding of phototherapy as well as concerns around side effects and harmful radiation. Better patient education and safety communication can therefore matter alongside product innovation.

Future Outlook

The Phototherapy Device Market will remain closely linked to chronic skin conditions, neonatal care and the move toward LED-based treatment. Hospitals will retain clinical importance, but home phototherapy gives manufacturers another route to patients who require repeated treatment and want to reduce facility visits.

The next competitive divide will separate companies that make phototherapy safer, simpler and more convenient across care settings from suppliers that remain dependent on legacy treatment models.

Browse More Trending Reports

Global Urinary Drainage Bags Market 

Cryptococcosis Treatment Market 

Analyst Perspective

“Phototherapy is moving toward a more flexible care model, with hospitals retaining clinical importance while LED technology and home treatment create new routes to patients. Suppliers that combine therapeutic performance with simpler deployment and patient convenience will be better positioned as treatment demand expands,” said Komal Patil, Analyst at Maximize Market Research.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

2nd Floor, Navale IT Park Phase 3

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India

+91 9607365656

sales@maximizemarketresearch.com 

https://www.maximizemarketresearch.com